SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Camilli Louis S

(Last)

(First)

(Middle)

C/O L2 MEDICAL DEVELOPMENT COMPANY

2451 ALAMO AVENUE SE

(Street)

ALBUQUERQUE

87106

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
L2 MEDICAL DEVELOPMENT CO [ SCQO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Pres, CTO & Secretary

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2013

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/04/2013		J⁽¹⁾		450,436	A	⁽¹⁾	450,436	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (Right to Buy)	$1.0057	09/04/2013		J⁽²⁾		89,495		⁽³⁾	08/06/2015	Common Stock	89,495	$0.00	89,495	D
Employee Stock Option (Right to Buy)	$1.0057	09/04/2013		J⁽²⁾		37,339		⁽⁴⁾	12/14/2016	Common Stock	37,339	$0.00	126,834	D
Employee Stock Option (Right to Buy)	$1.0057	09/04/2013		J⁽²⁾		29,832		⁽⁵⁾	12/03/2022	Common Stock	29,832	$0.00	156,666	D
Common Stock Warrant (Right to Buy)	$6.3976	09/04/2013		J⁽⁶⁾		15,537		09/04/2013	12/31/2016	Common Stock	15,537	$0.00	15,537	D

Explanation of Responses:

1. The Reporting Person received shares of common stock of the Issuer in exchange for shares of common stock of Enerpulse, Inc., a Delaware corporation ("Enerpulse"), in connection with the Merger Agreement by and among the Issuer, Enerpulse Merger Sub, Inc., a wholly-owned subsidiary of the Issuer, and Enerpulse.

2. The Reporting Person received options to purchase shares of common stock of the Issuer in consideration for the substitution of options to purchase shares of common stock of Enerpulse pursuant to the terms of the merger transaction by and among the Issuer, Enerpulse Merger Sub, Inc., a wholly-owned subsidiary of the Issuer, and Enerpulse.

3. 22,373 shares subject to the option vested on August 5, 2010. The remaining shares subject to the option shall vest and become exercisable upon change in control of the Issuer.

4. The shares subject to the option shall vest and become exercisable ratably in annual installments over three years beginning on December 15, 2011 until fully vested on December 15, 2014.

5. The shares subject to the option shall vest and become exercisable ratably in annual installments over three years beginning on December 4, 2012 until fully vested on December 4, 2015.

6. The Reporting Person has the right to exchange a warrant to purchase shares of common stock of Enerpulse for a substantially similar warrant issued by the Issuer following the consummation of the merger by and among the Issuer, Enerpulse Merger Sub, Inc., a wholly-owned subsidiary of the Issuer, and Enerpulse.

Remarks:

	/s/ Louis S. Camilli	09/06/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.